PXD035147 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Integrated proteome and malonylome analyses reveal the potential meaning of TLN1 and ACTB in end-stage renal disease |
Description | Purpose: End-stage renal disease (ESRD) is a condition that is characterized by the loss of kidney function. ESRD patients suffer from various endothelial dysfunctions, inflammation, and immune system defects. Lysine malonylation (Kmal) is a recently discovered post-translational modification (PTM). Although Kmal has the ability to regulate a wide range of biological processes in various organisms, its specific role in ESRD is limited. Experimental design: In this study, the affinity enrichment and liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques have been used to create the first global proteome and malonyl proteome (malonylome) profiles of peripheral blood mononuclear cells (PBMCs) from twenty patients with ESRD and eighty-one controls. Results: On analysis, 793 differentially expressed proteins (DEPs) and 12 differentially malonylated proteins (DMPs) with 16 Kmal sites were identified. The Rap1 signaling pathway and platelet activation pathway were found to be important in the development of chronic kidney disease (CKD), as were DMPs TLN1 and ACTB, as well as one malonylated site. One conserved Kmal motif was also discovered. Conclusion: These findings provided the first report on the Kmal profile in ESRD, which could be useful in understanding the potential role of lysine malonylation modification in the development of ESRD. |
HostingRepository | PRIDE |
AnnounceDate | 2023-11-14 |
AnnouncementXML | Submission_2023-11-14_09:06:52.280.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | ruqi tan |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | autoflex |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2022-07-07 01:02:46 | ID requested | |
1 | 2023-10-24 10:59:25 | announced | |
⏵ 2 | 2023-11-14 09:07:00 | announced | 2023-11-14: Updated project metadata. |
3 | 2024-10-22 06:08:22 | announced | 2024-10-22: Updated project metadata. |
Publication List
Tan R, Li D, Hu N, Qiu J, Zeng Z, Cai W, Zhong Y, Zhang X, Pai P, Wang K, Tang D, Dai Y, Integrated proteome and malonylome analyses reveal the potential meaning of TLN1 and ACTB in end-stage renal disease. Proteome Sci, 21(1):18(2023) [pubmed] |
Keyword List
submitter keyword: lysine malonylation (Kmal), platelet activation, post-translational modification (PTM), end-stage renal disease (ESRD), chronic kidney disease (CKD) |
Contact List
Ruqi Tan |
contact affiliation | Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, Guangdong;Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong |
contact email | 674909173@qq.com |
lab head | |
ruqi tan |
contact affiliation | Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, Guangdong;Department of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong |
contact email | 674909173@qq.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/10/PXD035147 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD035147
- Label: PRIDE project
- Name: Integrated proteome and malonylome analyses reveal the potential meaning of TLN1 and ACTB in end-stage renal disease